60 acast.com The Hep-cast https://feeds.acast.com/public/shows/the-hep-cast en World Hepatitis Alliance and Gilead Sciences Europe Limited 2020 Hepatitis, hepatitis c, HCV, virus, viral hepatitis, hepatitis virus, bloodborne virus, chronic hepatitis, liver disease, liver inflammation, liver failure, liver cirrhosis, liver cancer, hepatitis treatment, HCV treatment World Hepatitis Alliance and Gilead Sciences Europe Limited The real-life stories behind the fight to eliminate viral hepatitis

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> false BCW London info+5f479e4b62ffcb0e230eadfe@mg-eu.acast.com 5f479e4b62ffcb0e230eadfe the-hep-cast episodic https://assets.pippa.io/shows/undefined/1598528985308-fa78c4fee16bf6485d75d0e4a645e3ce.jpeg https://feeds.acast.com/public/shows/the-hep-cast The Hep-cast S2#4 Health equality: fighting for testing and treatment among migrant and refugee populations S2#4 Health equality: fighting for testing and treatment among migrant and refugee populations Wed, 19 Oct 2022 09:39:14 GMT 43:56 634fbb0c575a570012ff423f false https://shows.acast.com/the-hep-cast/episodes/fighting-for-testing-and-treatment-among-migrants 634fbb0c575a570012ff423f 5f479e4b62ffcb0e230eadfe fighting-for-testing-and-treatment-among-migrants full 2 4 “I never felt the need of sharing my story at work, because I don't know how much they know about hepatitis B, and the moment they know that hepatitis B is contagious they would judge me” says Sidney Vo, a hepatitis B advocate who found out she was living with hepatitis B when she was pregnant with her son in her home country of Vietnam in 2007. A year later, she moved to Australia to help fill the gap in their workforce in early childhood education. After a decade of living in the country Sidney applied for permanent residency, only to find she was met with barriers from the government. In the final episode of the Hep-cast series 2 , Sidney Vo joins Professor Maria Buti from Hospital General Universitari Valle Hebron, Barcelona, Professor Mohammad Ali from the National Liver Foundation of Bangladesh (NLFB) and Camila Picchio, a public health researcher from Barcelona Institute for Global Health (ISGlobal) to discuss the challenges and barriers to accessing testing in a traditional healthcare setting and key considerations that are needed to reach migrants and refugees populations.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job bag number: IHQ-UNB-2679

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> “I never felt the need of sharing my story at work, because I don't know how much they know about hepatitis B, and the moment they know that hepatitis B is contagious they would judge me” says Sidney Vo, a hepatitis B advocate who found out she was living with hepatitis B when she was pregnant with her son in her home country of Vietnam in 2007. A year later, she moved to Australia to help fill the gap in their workforce in early childhood education. After a decade of living in the country Sidney applied for permanent residency, only to find she was met with barriers from the government. In the final episode of the Hep-cast series 2 , Sidney Vo joins Professor Maria Buti from Hospital General Universitari Valle Hebron, Barcelona, Professor Mohammad Ali from the National Liver Foundation of Bangladesh (NLFB) and Camila Picchio, a public health researcher from Barcelona Institute for Global Health (ISGlobal) to discuss the challenges and barriers to accessing testing in a traditional healthcare setting and key considerations that are needed to reach migrants and refugees populations.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job bag number: IHQ-UNB-2679

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> S2 #3 Inside Prisons: The hepatitis care pathway for incarcerated people S2 #3 Inside Prisons: The hepatitis care pathway for incarcerated people Fri, 12 Aug 2022 15:15:39 GMT 44:08 62f66e9a251c33001333dcbe false https://shows.acast.com/the-hep-cast/episodes/the-hepatitis-care-pathway-for-incarcerated-people 62f66e9a251c33001333dcbe 5f479e4b62ffcb0e230eadfe the-hepatitis-care-pathway-for-incarcerated-people full 2 3 “We have these little conversations privately, as discreetly as possible, because there is a lot of stigma in prison settings… these guys know that we've been to prison so when we're speaking to some of these people, it really makes a difference” says Clive Williams, a peer support lead for The Hepatitis C Trust, who previously lived with hepatitis C and was treated and cured while in prison. In this episode, Clive Williams joins Dr. John May, President of Health Through Walls, and Dr. Sanjay Sarin, Vice President, Access at FIND to explore viral hepatitis within prison settings and interventions and experiences of people living with viral hepatitis in prison.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job bag number: IHQ-UNB-2268

Date of preparation: July 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> “We have these little conversations privately, as discreetly as possible, because there is a lot of stigma in prison settings… these guys know that we've been to prison so when we're speaking to some of these people, it really makes a difference” says Clive Williams, a peer support lead for The Hepatitis C Trust, who previously lived with hepatitis C and was treated and cured while in prison. In this episode, Clive Williams joins Dr. John May, President of Health Through Walls, and Dr. Sanjay Sarin, Vice President, Access at FIND to explore viral hepatitis within prison settings and interventions and experiences of people living with viral hepatitis in prison.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job bag number: IHQ-UNB-2268

Date of preparation: July 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> S2 #2 Youth Can’t Wait – Empowering Young People in the Fight against Hepatitis S2 #2 Youth Can’t Wait – Empowering Young People in the Fight against Hepatitis Tue, 14 Jun 2022 14:43:31 GMT 45:51 62a89e937a90a80012498217 false https://shows.acast.com/the-hep-cast/episodes/empowering-young-people-in-the-fight-against-hepatitis 62a89e937a90a80012498217 5f479e4b62ffcb0e230eadfe empowering-young-people-in-the-fight-against-hepatitis full 2 2 David Urick was born with hepatitis B but was only told when he was teenager. The confusion and stigma that followed had a profound and life changing impact on overcoming drug use, attempted suicide and depression. In this episode, David from the U.S. joins Professor Manal El-Sayed, a professor of paediatrics at Ain Shams University in Egypt, and Arafat Bwambale, Co-founder of the Great Lakes Peace Centre in Uganda to discuss the critical importance of working with young people to achieve elimination of viral hepatitis by 2030.

 

The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.

Job bag number: IHQ-UNB-1416


Date of preparation: April 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> David Urick was born with hepatitis B but was only told when he was teenager. The confusion and stigma that followed had a profound and life changing impact on overcoming drug use, attempted suicide and depression. In this episode, David from the U.S. joins Professor Manal El-Sayed, a professor of paediatrics at Ain Shams University in Egypt, and Arafat Bwambale, Co-founder of the Great Lakes Peace Centre in Uganda to discuss the critical importance of working with young people to achieve elimination of viral hepatitis by 2030.

 

The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.

Job bag number: IHQ-UNB-1416


Date of preparation: April 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> S2 #1 Women Leading the Fight to Protect the Next Generation from Hepatitis S2 #1 Women Leading the Fight to Protect the Next Generation from Hepatitis Mon, 23 May 2022 08:33:13 GMT 47:18 6257022e90ef350012b54025 false https://shows.acast.com/the-hep-cast/episodes/women-leading-the-fight-to-protect-the-next-generation 6257022e90ef350012b54025 5f479e4b62ffcb0e230eadfe women-leading-the-fight-to-protect-the-next-generation full 2 1 “I was nervous being a first-time mum, but also about potentially passing hepatitis B to my child” says Nafisa Yussf, a Hepatitis Community Advocate living with hepatitis B in Australia. 

In this first episode of series 2, Dr Sarah Jarvis is joined by Nafisa Yussf and two other passionate women: Cynthia Raissa Tamandjou, a Medical Virologist based in France and Bisi Bright, a Clinical Pharmacist and CEO of the LiveWell Initiative in Nigeria. These inspiring women have dedicated their lives to empowering women and mothers living with viral hepatitis, challenging misconceptions and tackling the stigma to improve the lives of others.   


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited. 


Job bag number: IHQ-UNB-1415 

Date of preparation: April 2022 

 

Hosted on Acast. See acast.com/privacy for more information.

]]> “I was nervous being a first-time mum, but also about potentially passing hepatitis B to my child” says Nafisa Yussf, a Hepatitis Community Advocate living with hepatitis B in Australia. 

In this first episode of series 2, Dr Sarah Jarvis is joined by Nafisa Yussf and two other passionate women: Cynthia Raissa Tamandjou, a Medical Virologist based in France and Bisi Bright, a Clinical Pharmacist and CEO of the LiveWell Initiative in Nigeria. These inspiring women have dedicated their lives to empowering women and mothers living with viral hepatitis, challenging misconceptions and tackling the stigma to improve the lives of others.   


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited. 


Job bag number: IHQ-UNB-1415 

Date of preparation: April 2022 

 

Hosted on Acast. See acast.com/privacy for more information.

]]> Series 2 Trailer Series 2 Trailer Tue, 10 May 2022 11:11:33 GMT 1:24 6257009041eb8300141d36a7 false https://shows.acast.com/the-hep-cast/episodes/series-2-trailer 6257009041eb8300141d36a7 5f479e4b62ffcb0e230eadfe series-2-trailer trailer 2 In Series Two of the Hep-cast we will focus on the lives of those impacted by viral hepatitis globally, including mothers, young people, people who have been incarcerated, refugees and migrants.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job bag number: IHQ-UNB-1408

Date of preparation: May 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> In Series Two of the Hep-cast we will focus on the lives of those impacted by viral hepatitis globally, including mothers, young people, people who have been incarcerated, refugees and migrants.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job bag number: IHQ-UNB-1408

Date of preparation: May 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> S1 #7 The Global Movement to Eliminate Viral Hepatitis S1 #7 The Global Movement to Eliminate Viral Hepatitis Mon, 18 Jan 2021 18:42:39 GMT 46:07 6005cb090b7d13509619c1e4 false https://shows.acast.com/the-hep-cast/episodes/7-the-global-movement-to-eliminate-viral-hepatitis 6005cb090b7d13509619c1e4 5f479e4b62ffcb0e230eadfe 7-the-global-movement-to-eliminate-viral-hepatitis full 1 7 In this season's final episode, our panel discusses the power of the global hepatitis movement and their willingness to achieve the elimination of viral hepatitis as a public health threat, including how to overcome the challenges that lie ahead. Our host, Dr Sarah Jarvis, is joined by Charles Gore, hepatitis advocate and founder of the World Hepatitis Alliance (WHA), Dr Su Wang, President of the WHA, Homie Razavi, MD of Center for Disease Analysis Foundation, and John Ward, Director of the Coalition for Global Hepatitis Elimination at the Task Force for Global Health.

The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.

Job bag number: IHQ-HCV-2020-12-0015

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> In this season's final episode, our panel discusses the power of the global hepatitis movement and their willingness to achieve the elimination of viral hepatitis as a public health threat, including how to overcome the challenges that lie ahead. Our host, Dr Sarah Jarvis, is joined by Charles Gore, hepatitis advocate and founder of the World Hepatitis Alliance (WHA), Dr Su Wang, President of the WHA, Homie Razavi, MD of Center for Disease Analysis Foundation, and John Ward, Director of the Coalition for Global Hepatitis Elimination at the Task Force for Global Health.

The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.

Job bag number: IHQ-HCV-2020-12-0015

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> S1 #6 UK in Focus: Collaborate to Eliminate S1 #6 UK in Focus: Collaborate to Eliminate Mon, 04 Jan 2021 15:03:10 GMT 41:21 5fe32b6d728e2c6c3e0cba99 false https://shows.acast.com/the-hep-cast/episodes/6-uk-in-focus-collaborate-to-eliminate 5fe32b6d728e2c6c3e0cba99 5f479e4b62ffcb0e230eadfe 6-uk-in-focus-collaborate-to-eliminate full 1 6 This episode speaks to three women whose organisations are working together to achieve the elimination of hepatitis C in their community. Our host, Dr Sarah Jarvis, is joined by Shabana Begum, the South Asian Project Officer at The Hepatitis C Trust, Stacey Smith, Director of Nursing at Humankind and Diane Williams, Hepatitis C Network Manager for the West Yorkshire Operational Delivery Network.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job code: IHQ-HCV-2020-10-0077

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> This episode speaks to three women whose organisations are working together to achieve the elimination of hepatitis C in their community. Our host, Dr Sarah Jarvis, is joined by Shabana Begum, the South Asian Project Officer at The Hepatitis C Trust, Stacey Smith, Director of Nursing at Humankind and Diane Williams, Hepatitis C Network Manager for the West Yorkshire Operational Delivery Network.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job code: IHQ-HCV-2020-10-0077

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> S1 #5 UK in Focus: Elimination is Possible S1 #5 UK in Focus: Elimination is Possible Mon, 14 Dec 2020 13:58:51 GMT 45:47 5fd7399e399c7b6cd106082a false https://shows.acast.com/the-hep-cast/episodes/5-uk-in-focus-elimination-is-possible 5fd7399e399c7b6cd106082a 5f479e4b62ffcb0e230eadfe 5-uk-in-focus-elimination-is-possible full 1 5 In the first of our two ‘UK in Focus’ episodes, our panel discusses the current status of hepatitis C elimination in the UK and share good practice initiatives that are making elimination possible. Our host, Dr Sarah Jarvis, is joined by Professor Graham Foster, Professor of Hepatology at Queen Mary University of London, Rachel Halford, CEO of the Hepatitis C Trust and Professor John Dillon, Professor of Hepatology and Gastroenterology at University of Dundee. 


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.

Job bag IHQ-HCV-2020-10-0073

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> In the first of our two ‘UK in Focus’ episodes, our panel discusses the current status of hepatitis C elimination in the UK and share good practice initiatives that are making elimination possible. Our host, Dr Sarah Jarvis, is joined by Professor Graham Foster, Professor of Hepatology at Queen Mary University of London, Rachel Halford, CEO of the Hepatitis C Trust and Professor John Dillon, Professor of Hepatology and Gastroenterology at University of Dundee. 


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.

Job bag IHQ-HCV-2020-10-0073

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> S1 #4 Ending the chain of transmission S1 #4 Ending the chain of transmission Tue, 24 Nov 2020 09:12:06 GMT 45:09 5fbcce567c3f4b4af6276da3 false https://shows.acast.com/the-hep-cast/episodes/episode-4-ending-the-chain-of-transmission 5fbcce567c3f4b4af6276da3 5f479e4b62ffcb0e230eadfe episode-4-ending-the-chain-of-transmission full 1 4 This episode focuses on the role of harm reduction services in protecting vulnerable people from hepatitis C. Host Sarah Jarvis hears from Heidi Fridriksdottir, Project Manager of the TrapHepC initiative in Iceland – where they have already reached the WHO service targets for hepatitis C elimination –, Aura Roig, Director of the grass-roots, women-focussed Metzineres organization in Barcelona and Jodie Albert, a Community Outreach Worker in the Atahkakoop Know Your Status hepatitis C program, a rural First Nation community in Canada.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.

Job bag: IHQ-HCV-2020-10-0031

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> This episode focuses on the role of harm reduction services in protecting vulnerable people from hepatitis C. Host Sarah Jarvis hears from Heidi Fridriksdottir, Project Manager of the TrapHepC initiative in Iceland – where they have already reached the WHO service targets for hepatitis C elimination –, Aura Roig, Director of the grass-roots, women-focussed Metzineres organization in Barcelona and Jodie Albert, a Community Outreach Worker in the Atahkakoop Know Your Status hepatitis C program, a rural First Nation community in Canada.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.

Job bag: IHQ-HCV-2020-10-0031

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> S1 #3 Breaking Barriers to Treatment S1 #3 Breaking Barriers to Treatment Mon, 09 Nov 2020 17:34:17 GMT 38:52 5fa97dd60b16923861d45249 false https://shows.acast.com/the-hep-cast/episodes/episode-3-breaking-barriers-to-treatment 5fa97dd60b16923861d45249 5f479e4b62ffcb0e230eadfe episode-3-breaking-barriers-to-treatment full 1 3 In this episode our focus turns to treatment as we explore the power of cure and how to successfully take treatment to the people who need it most. Host Sarah Jarvis is joined by Maka Gogia, Program Director of the Georgian Harm Reduction Network, George Kalamitsis, Chair of the Hellenic Liver Patient Association in Athens and Alex Thompson, Director of Gastroenterology at St Vincent’s Hospital in Melbourne. 


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job code: IHQ-HCV-2020-10-0084

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> In this episode our focus turns to treatment as we explore the power of cure and how to successfully take treatment to the people who need it most. Host Sarah Jarvis is joined by Maka Gogia, Program Director of the Georgian Harm Reduction Network, George Kalamitsis, Chair of the Hellenic Liver Patient Association in Athens and Alex Thompson, Director of Gastroenterology at St Vincent’s Hospital in Melbourne. 


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job code: IHQ-HCV-2020-10-0084

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> S1 #2 Finding the Missing Millions S1 #2 Finding the Missing Millions Mon, 26 Oct 2020 15:25:47 GMT 40:25 5f96ea7b27f5851c5e3c765f false https://shows.acast.com/the-hep-cast/episodes/episode-2-finding-the-missing-millions 5f96ea7b27f5851c5e3c765f 5f479e4b62ffcb0e230eadfe episode-2-finding-the-missing-millions full 1 2 This second episode focusses on testing and how finding the ‘missing millions’ is essential to eliminate hepatitis C. Our host, Dr Sarah Jarvis, is joined by Manal El Sayed from the Egyptian National Committee for the Control of Viral Hepatitis, Sonjelle Shilton, Deputy Head of HCV access at Global NGO FIND and Jennifer Slepin, who co-founded HepCarestream in the USA after being cured of hepatitis C.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited. 

Job code: IHQ-UNB-2480

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> This second episode focusses on testing and how finding the ‘missing millions’ is essential to eliminate hepatitis C. Our host, Dr Sarah Jarvis, is joined by Manal El Sayed from the Egyptian National Committee for the Control of Viral Hepatitis, Sonjelle Shilton, Deputy Head of HCV access at Global NGO FIND and Jennifer Slepin, who co-founded HepCarestream in the USA after being cured of hepatitis C.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited. 

Job code: IHQ-UNB-2480

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> S1 #1 Engagement S1 #1 Engagement Fri, 16 Oct 2020 11:12:51 GMT 42:11 5f7767111850957b0d08d37b false https://shows.acast.com/the-hep-cast/episodes/episode-1-engagement 5f7767111850957b0d08d37b 5f479e4b62ffcb0e230eadfe episode-1-engagement full 1 1 This first episode explores how people who have been affected by hepatitis C are leading the fight against the virus in their communities. Sarah Jarvis, our host, is joined by Cary James of the World Hepatitis Alliance, Professor Carla Treloar from the University of New South Wales and Tony McClure from the Hepatitis C Trust.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job code: IHQ-HCV-2020-10-0001

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> This first episode explores how people who have been affected by hepatitis C are leading the fight against the virus in their communities. Sarah Jarvis, our host, is joined by Cary James of the World Hepatitis Alliance, Professor Carla Treloar from the University of New South Wales and Tony McClure from the Hepatitis C Trust.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job code: IHQ-HCV-2020-10-0001

Date of preparation: September 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> Trailer Trailer Thu, 27 Aug 2020 18:55:40 GMT 1:42 5f48013a9654ee77b1c568cd false https://shows.acast.com/the-hep-cast/episodes/trailer 5f48013a9654ee77b1c568cd 5f479e4b62ffcb0e230eadfe trailer trailer The Hep-cast is about the people fighting to eliminate hepatitis C (HCV), a silent killer that affects 71 million people worldwide. Join us as we go beyond the statistics to explore the human impact of this crisis.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job code: IHQ-HCV-2020-08-0013

Date of preparation: May 2022

Hosted on Acast. See acast.com/privacy for more information.

]]> The Hep-cast is about the people fighting to eliminate hepatitis C (HCV), a silent killer that affects 71 million people worldwide. Join us as we go beyond the statistics to explore the human impact of this crisis.


The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.


Job code: IHQ-HCV-2020-08-0013

Date of preparation: May 2022

Hosted on Acast. See acast.com/privacy for more information.

]]>